Edition:
United Kingdom

People: Varian Medical Systems Inc (VAR.N)

VAR.N on New York Stock Exchange

132.96USD
23 Jul 2019
Change (% chg)

$0.79 (+0.60%)
Prev Close
$132.17
Open
$132.35
Day's High
$133.09
Day's Low
$131.52
Volume
129,106
Avg. Vol
151,221
52-wk High
$142.50
52-wk Low
$101.44

Toth, Chris 

Mr. Chris Toth is President - Varian Oncology Systems of the Company. Christopher A. Toth was appointed President of Oncology Systems effective October 2018. Mr. Toth joined Varian in 2001 and has held multiple cross-functional roles and executive positions during his tenure with the company. Prior to his appointment as President of Oncology Systems, Mr. Toth served as President of Global Commercial and Field Operations from January 2017 to September 2018, where he was responsible for global sales strategy and execution for Oncology Systems and Proton Solutions. Additionally, in this role, Mr. Toth was responsible for global field service, applications training, market access and regional marketing for the Oncology Systems business. From September 2014 to January 2017, Mr. Toth was President, Oncology Systems Americas and from April 2011 to September 2014, Vice President, Global Marketing. Mr. Toth holds a B.A. degree in Business Administration with a concentration in Marketing from the Lundquist College of Business at the University of Oregon.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

R. Andrew Eckert

444,750

Dow Wilson

10,276,400

Timothy Guertin

270,500

Gary Bischoping

2,873,880

Chris Toth

--

Kolleen Kennedy

3,933,970
As Of  28 Sep 2018